Source comparison
BPC-157 vs Standard Gut Healing Interventions: Mechanism Comparison
BPC-157 Direct upregulation of occludin, claudin-1, ZO-1 mRNA; suppression of TNF-α and IL-6 Direct structural repair. Increases protein synthesis and membrane localisation 48–72 hours in rodent models The only intervention that directly increases tight juncti
This comparison does not assign a generated winner or score.
- BPC-157
- Direct upregulation of occludin, claudin-1, ZO-1 mRNA; suppression of TNF-α and IL-6
- Direct structural repair. Increases protein synthesis and membrane localisation
- 48–72 hours in rodent models
- The only intervention that directly increases tight junction protein transcription. Not reliant on downstream anti-inflammatory effects.
- L-Glutamine
- Serves as primary fuel for enterocytes; supports mucosal regeneration
- Indirect. Reduces oxidative stress that degrades tight junctions
- 2–4 weeks for measurable barrier function improvement
- Essential for enterocyte health but doesn't directly upregulate tight junction genes. Works best as a substrate, not a signalling molecule.
- Zinc Carnosine
- Stabilises existing tight junction proteins via antioxidant activity
- Protective. Prevents oxidative degradation of occludin and claudin
- 4–8 weeks for clinical symptom improvement
- Effective at preventing further damage but slower at rebuilding barrier integrity once junctions are already degraded.
- Probiotics (Lactobacillus, Bifidobacterium)
- Modulates gut microbiome; reduces pathogenic bacterial translocation
- Indirect. Reduces LPS load that triggers inflammatory tight junction breakdown
- 6–12 weeks for microbiome remodelling
- Critical for long-term maintenance but doesn't address existing structural damage. Works upstream of barrier repair.
- Butyrate (Short-Chain Fatty Acid)
- Fuel source for colonocytes; anti-inflammatory via HDAC inhibition
- Indirect. Reduces inflammatory cytokines that degrade junctions
- 4–6 weeks for detectable barrier function changes
- Strong anti-inflammatory effects but relies on a healthy microbiome to produce sufficient butyrate endogenously.
- BPC-157 is the only intervention in this comparison that directly increases tight junction protein gene expression. The others modulate inflammation, oxidative stress, or microbial balance, which indirectly supports barrier function. For acute repair of established hyperpermeability, the direct genomic effect matters. For long-term maintenance, combining BPC-157 with microbiome-targeted interventions (probiotics, butyrate) addresses both structural repair and upstream drivers of permeability.